{"id":"euflexxa","rwe":[{"pmid":"34745480","year":"2021","title":"A Comprehensive Review of Viscosupplementation in Osteoarthritis of the Knee.","finding":"","journal":"Orthopedic reviews","studyType":"Clinical Study"},{"pmid":"34515539","year":"2021","title":"Risk of Severe Acute Localized Reactions for Different Intraarticular Hyaluronic Acid Knee Injections in a Real-World Setting.","finding":"","journal":"Cartilage","studyType":"Clinical Study"},{"pmid":"34369721","year":"2021","title":"Delay to TKA in Patients Treated with a Multimodal Approach Using High Molecular Weight, Biologically Derived Hyaluronic Acid.","finding":"","journal":"Journal of long-term effects of medical implants","studyType":"Clinical Study"},{"pmid":"34044600","year":"2021","title":"Intraarticular Hyaluronic Acid Preparations for Knee Osteoarthritis: Are Some Better Than Others?","finding":"","journal":"Cartilage","studyType":"Clinical Study"},{"pmid":"33426208","year":"2020","title":"PPAR-δ agonist affects adipo-chondrogenic differentiation of human mesenchymal stem cells through the expression of PPAR-γ.","finding":"","journal":"Regenerative therapy","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Georgia Institute for Clinical Research, LLC","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":["hyaluronic acid injection"],"company":"Georgia Institute for Clinical Research, LLC","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=EUFLEXXA","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:59:08.018884+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:59:14.357564+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=EUFLEXXA","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:59:15.094630+00:00"}},"allNames":["euflexxa"],"offLabel":[],"synonyms":[],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Due to the lack of available information, the technical pharmacology detail of Euflexxa's mechanism of action is currently unknown."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=euflexxa","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=euflexxa","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:28:51.918281","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:59:17.328707+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"euflexxa","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03459365","phase":"NA","title":"Euflexxa for the Treatment of Osteoarthritis","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2018-07-09","conditions":["Osteo Arthritis Knee"],"enrollment":30,"completionDate":"2021-10-31"},{"nctId":"NCT06463132","phase":"PHASE1","title":"Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA)","status":"NOT_YET_RECRUITING","sponsor":"Rion Inc.","startDate":"2024-11-01","conditions":["Knee Osteoarthritis"],"enrollment":24,"completionDate":"2025-11-01"},{"nctId":"NCT03491761","phase":"PHASE2","title":"Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2018-06-13","conditions":["Knee Osteoarthritis"],"enrollment":100,"completionDate":"2027-12"},{"nctId":"NCT03293238","phase":"NA","title":"Ultrasound Guided Knee Injections in Musculoskeletal Medicine","status":"COMPLETED","sponsor":"Andrews Research & Education Foundation","startDate":"2011-11-03","conditions":["Knee Osteoarthritis"],"enrollment":63,"completionDate":"2018-02"},{"nctId":"NCT02671565","phase":"","title":"Comparative Effectiveness of Hyaluronic Acid Injections for Management of Knee Osteoarthritis","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2016-02","conditions":["Knee Osteoarthritis"],"enrollment":13849,"completionDate":"2016-07"},{"nctId":"NCT02110238","phase":"NA","title":"Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA","status":"COMPLETED","sponsor":"Bioventus LLC","startDate":"2014-03","conditions":["Osteoarthritis"],"enrollment":421,"completionDate":"2015-02"},{"nctId":"NCT01895959","phase":"PHASE4","title":"To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2013-08","conditions":["Knee Osteoarthritis"],"enrollment":12,"completionDate":"2017-01"},{"nctId":"NCT02495857","phase":"NA","title":"A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2015-08-15","conditions":["Osteoarthritis"],"enrollment":599,"completionDate":"2016-12-05"},{"nctId":"NCT01811654","phase":"NA","title":"Effectiveness Trial for Evaluating IAHA for PFPS","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2013-04","conditions":["Patellofemoral Pain Syndrome"],"enrollment":30,"completionDate":"2017-03-04"},{"nctId":"NCT01256788","phase":"NA","title":"Post-op Treatment With Hyaluronic Acid Injections","status":"TERMINATED","sponsor":"The Hawkins Foundation","startDate":"2010-09","conditions":["Meniscus Tear","Chondropathy/Degenerative Joint Disease (DJD)"],"enrollment":34,"completionDate":"2014-04"},{"nctId":"NCT02640144","phase":"PHASE4","title":"The Influence of Hyaluronic Acid Injection Following Knee Arthroscopy","status":"UNKNOWN","sponsor":"Ziv Medical Center","startDate":"2017-02","conditions":["Cartilage Damage"],"enrollment":60,"completionDate":"2018-04"},{"nctId":"NCT01557868","phase":"PHASE4","title":"Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis","status":"COMPLETED","sponsor":"American Orthopaedic Society for Sports Medicine","startDate":"2008-10","conditions":["Osteoarthritis, Knee"],"enrollment":198,"completionDate":"2012-12"},{"nctId":"NCT00969501","phase":"NA","title":"Three Injections of EUFLEXXA (Sodium Hyaluronate) for Treatment of Chronic Shoulder Pain Associated With Osteoarthritis (OA)","status":"COMPLETED","sponsor":"Georgia Institute for Clinical Research, LLC","startDate":"2009-08","conditions":["Osteoarthritis"],"enrollment":32,"completionDate":"2010-08"},{"nctId":"NCT00379236","phase":"NA","title":"A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2006-10","conditions":["Osteoarthritis, Knee"],"enrollment":588,"completionDate":"2008-05"},{"nctId":"NCT00423371","phase":"PHASE2,PHASE3","title":"Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2006-12","conditions":["Osteoarthritis"],"enrollment":79,"completionDate":"2007-09"},{"nctId":"NCT00782197","phase":"PHASE4","title":"Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OA","status":"COMPLETED","sponsor":"Biotechnology Institute IMASD","startDate":"2008-01","conditions":["Joint Disease"],"enrollment":240,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Georgia Institute for Clinical Research, LLC","relationship":"Original Developer"}],"publicationCount":24,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Georgia Institute for Clinical Research, LLC","recentPublications":[{"date":"2021","pmid":"34745480","title":"A Comprehensive Review of Viscosupplementation in Osteoarthritis of the Knee.","journal":"Orthopedic reviews"},{"date":"2021 Dec","pmid":"34515539","title":"Risk of Severe Acute Localized Reactions for Different Intraarticular Hyaluronic Acid Knee Injections in a Real-World Setting.","journal":"Cartilage"},{"date":"2021","pmid":"34369721","title":"Delay to TKA in Patients Treated with a Multimodal Approach Using High Molecular Weight, Biologically Derived Hyaluronic Acid.","journal":"Journal of long-term effects of medical implants"},{"date":"2021 Dec","pmid":"34044600","title":"Intraarticular Hyaluronic Acid Preparations for Knee Osteoarthritis: Are Some Better Than Others?","journal":"Cartilage"},{"date":"2020 Dec","pmid":"33426208","title":"PPAR-δ agonist affects adipo-chondrogenic differentiation of human mesenchymal stem cells through the expression of PPAR-γ.","journal":"Regenerative therapy"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"EUFLEXXA","companyName":"Georgia Institute for Clinical Research, LLC","companyId":"georgia-institute-for-clinical-research-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:59:17.328707+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}